Scott M. Rocklage Ph.D. is managing partner at 5AM Venture Management LLC. He joined the company as a venture partner and was promoted to his current position in 2004.
Rocklage graduated from UC Berkley with a bachelor’s degree in chemistry and went on to M.I.T. where he earn a Ph.D. in Chemistry. While at M.I.T., Rocklage worked in the lab of Richard R. Schrock, the Nobel Prize winner, doing research. Dr. Rocklage holds more than 30 U.S. patents and his work has appeared in over 100 peer-reviewed publications. He has also helped get FDA approval for several drugs.
Prior to working with 5AM Venture Management, Dr. Rocklage held executive positions with several biotech companies. He was CEO of EPIRUS Biopharmaceuticals, president and CEO of Amersham Health and co-president of Ilypsa. Dr. Rocklage also served as founding CEO and president of Cubist Pharmaceuticals. He was also Nycomed Salutar’s president and CEO and served as Nycomed Interventional’s CEO, president and chairman. He also held a number of R&D positions with Salutar and Catalytica Pharmaceuticals and is Cidara Therapeutics’ board chairman. Dr. Rocklage is also on the board of Novira Therapeutics, Rennovia, Kinestral, the Whitehead Institute, Nouscom AG, MDS Proteomics, Semprus BioSciences Corp., Relypsa and Cubist Pharmaceuticals.
Dr. Scott Rocklage has an extensive scientific background, vast experience in healthcare management and an exemplary track record for strategic leadership. He has held executive and directorial positions in a vast number of companies. Currently based in 5AM Venture Management’s Waltham, Massachusetts office, Scott Rocklage has spent the past 30 years working with entrepreneurs who are scientists, physicians or business executives helping them shape their ideas into medicines to address unmet medical needs. He’s excited about the explosive growth of targeted cancer treatments that save, extend and improve the quality of people’s lives.
One of the reasons Dr. Rocklage has been so successful is because he’s very well organized when it comes to calendaring, prioritization and time management. He advises budding entrepreneurs to embrace measured risk-taking if they want to succeed. Dr. Scott Rocklage also recommends reading “Good to Great” to better understand business and performance.
Connect with Dr. Scott Rocklage on LinkedIn.